Results 31 to 40 of about 845,425 (163)

EXPERIENCE OF USING THE TB DRUG OF PERCHLOZON IN TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE IN BURYATIA REPUBLIC

open access: yesТуберкулез и болезни лёгких, 2015
Lately the main TB epidemiological rates are becoming stable in Buryatia Republic. In 2013-2014 the e¾ciency of use of perchlozon was studied within integral treatment of pulmonary tuberculosis patients with multiple and extensive drug resistance (MDR ...
S. V. Nikolaeva
doaj  

Multiple drug resistance in Aeromonas hydrophila isolates of fish [PDF]

open access: yesVeterinary World, 2010
Fourteen antibacterial agents belonging to 9 different groups of antibiotics viz. aminoglycosides, cephalosporins, nitrofurantoin, fluroquinolones, chloramphenicol, sulphonamides, tetracyclines, penicillin and polymixin were used for in vitro sensitivity
Kaskhedikar, M. and Chhabra, D
doaj  

Rational Targeting of Cdc42 Overcomes Drug Resistance of Multiple Myeloma

open access: yesFrontiers in Oncology, 2019
Multiple myeloma (MM) drug resistance highlights a need for alternative therapeutic strategies. In this study, we show that CASIN, a selective inhibitor of cell division cycle 42 (Cdc42) GTPase, inhibited proliferation and survival of melphalan ...
Phuong Nguyen   +13 more
doaj   +1 more source

Effect of Mutation in Efflux Pump Regulatory Protein (MexR) of Pseudomonas aeruginosa: A Bioinformatic Study

open access: yesMedical Laboratory Journal, 2017
Background and Objectives: Pseudomonas aeruginosa is an important non-fermenting gram-negative hospital-acquired pathogen. Treatment of P. aeruginosa infections has become more challenging due to overexpression of efflux pumps.
Hamid Vaez, Vahid Vaez, Farzad Khademi
doaj  

Role of epigenetics-microRNA axis in drug resistance of multiple myeloma

open access: yesJournal of Hematology & Oncology, 2017
Despite administration of novel therapies, multiple myeloma (MM) remains incurable with resistance to drugs leading to relapse in most patients. Thus, it is critical to understand the detailed mechanisms underlying the drug resistance of MM and develop ...
Nasrin Rastgoo   +3 more
doaj   +1 more source

Research progress on ferroptosis in drug resistance of tumor

open access: yesZhongguo aizheng zazhi, 2020
Drug resistance is a complicated process with multiple gene and signaling pathways. Multiple evidences demonstratethat reactive oxygen species (ROS) unbalance inducing oxidative stress defense and ROS-related ferroptosis are significantly involved in ...
程 淇, 易晓芳
doaj  

Antibiotic resistance pattern and distribution of Vietnamese extended-spectrum- β lactamase (VEB-1) gene in Acinetobacter baumannii isolated from hospitalized patients in Kashan Shahid Beheshti hospital during 2013-2014

open access: yesFiyz̤, 2017
Background: Acinetobacter baumannii are widely distributed pathogens in hospitals. They have the ability to have various mechanisms of resistance. Multiple drug resistant (MDR) strains of A. baumannii have created therapeutic problems worldwide.
Nahid Madadi-Goli   +2 more
doaj  

Acinetobacter: an underrated foodborne pathogen?

open access: yesJournal of Infection in Developing Countries, 2017
The increasing prevalence of foodborne diseases observed in developing countries has been linked to a rise in the consumption of raw foods. However, unlike the classical pathogens that are commonly implicated in foodborne illnesses, members of the genus ...
Angelo Maximo Batista de Amorim   +1 more
doaj   +1 more source

Resistencia a drogas de segunda línea en cepas peruanas de Mycobacterium tuberculosis multidrogorresistentes

open access: yesRevista Peruana de Medicina Experimental y Salud Pública
Objetivos. Determinar los perfiles de resistencia de las quinolonas; ciprofloxacina (Cpx), ofloxacina (Ofx), gatifloxacina (Gfx) y moxifloxacina (Mfx), y de los inyectables; kanamicina (Km), amikacina (Am) y capreomicina (Cm) en cepas ...
Francesca Barletta   +3 more
doaj  

MicroRNA-665 and its potential role in drug response and survival outcomes in multiple myeloma: a preliminary study

open access: yesFrontiers in Pharmacology
BackgroundMultiple myeloma (MM) is a complex hematological malignancy with heterogeneous clinical and pathophysiological backgrounds that influence treatment responses and outcomes.
Rui Bergantim   +23 more
doaj   +1 more source

Home - About - Disclaimer - Privacy